Please login to the form below
depression
This page shows the latest depression news and features for those working in and with pharma, biotech and healthcare.
Janssen submits esketamine in Europe for treatment resistant depression
Janssen has filed its new nasal spray-administered treatment for treatment resistant depression with the European Medicines Agency (EMA). ... Esketamine is a glutamate receptor modulator, for treatment-resistant depression (TRD) in adults with Major
Latest news
-
New data keeps AbbVie’s star pipeline therapies on track
There were also significant improvements for AbbVie’s drug over Humira on quality of life measures and over Stelara on anxiety and depression, and risankizumab did better than both comparator drugs
-
Daily Brief: another departure at Gilead, veteran researcher to head Karuna
Steven Paul, a veteran researcher who played a key role in developing Lilly’s antipsychotic and depression blockbuster drugs such as Zyprexa and Cymbalta is to head up efforts to find
-
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
researchers’time). Many of the proposed projects address brain disorders, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, major depression, and immune-mediated diseases such as Crohn’s
-
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
researchers’time). Many of the proposed projects address brain disorders, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, major depression, and immune-mediated diseases such as Crohn’s
-
Sage surges after depression drug gets rapid path to approval
Sage surges after depression drug gets rapid path to approval. Will be able to file a marketing application based on its phase II trial. ... The FDA has given its blessing to an expedited development route for Sage Therapeutics’depression pill SAGE-217,
More from news
Approximately 23 fully matching, plus 312 partially matching documents found.
Latest Intelligence
-
Health on instalment
The real estate collapse sparked by the Great Depression inspired the US to invent the 30-year mortgage. ... But the Depression annihilated all that refinance money overnight, leaving millions in the lurch.
-
Speech therapy
The first of these studies looked at ‘Woebot’, a Facebook Messenger bot delivering text-based cognitive behavioural therapy, which successfully reduced self-reported symptoms of depression in its users.
-
Finding the patient voice
With chronic conditions (15%) or fighting mental illness like depression (12%), most of them hope to find a permanent solution by joining a trial.
-
Reading human behaviour to create a medical future
series of cue cards to enable them to talk about difficult topics such as alcohol consumption and depression - which are key to their treatment yet often overlooked - with their physicians, and
-
Here’s to all the bright sparks
Or marketing revolutionary total knee replacements to defining new cures for depression… The future of healthcare is a wonderful place.
More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.
Latest appointments
-
Clark Health Communications expands team
responsible for driving the delivery of CHC’s gastroenterology, women’s health, depression and anticoagulants business.
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
-
Lundbeck promotes Andreas Eggert and Klaus Abel to senior commercial roles
vortioxetine for major depression and Selincro (nalmefene) for alcohol dependence. ... including a once-monthly aripiprazole formulation for the treatment of schizophrenia and brexpiprazole (OPC-34712) for the treatment of schizophrenia and major
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Neurostimulation Market Global Industry Analysis, Trends and Forecast, 2015 - 2025
Neurostimulation is used for the treatment of various debilitating conditions such as gastroparesis, incontinence, Parkinson’ s disease, epilepsy, depression and essential tremors. ... Deep brain stimulators are currently approved for the treatment of
-
Mental health in the workplace
Managing mental health conditions (such as stress, anxiety, depression and obsessive– compulsive disorder) remains a challenge, despite the recent efforts of many companies to implement policies to support a healthy workforce.
-
AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH
there’ s an abundance of smart thinking on how to improve the lives of people who struggle with major depression, schizophrenia, bipolar disorder, and other serious conditions.
-
Mental Health Patient Advocacy Groups in EU Say Strong Partnerships with Government and Industry Can Ensure Forward Progress
2 Six out of the 20 countries with the highest suicide rates in the world are in the European Region2 and in many EU Member States, depression is already the most ... Last accessed 8 January 2017. 3 European Depression Association Depression Manifesto: A
-
Clark Health Communications named Small Consultancy of the Year
and explore a specific population of depression patients; those who only partially respond to their medication.
More from PMHub
Approximately 4 fully matching, plus 25 partially matching documents found.
Featured jobs
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Senior Account Manager
-
Negotiable
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
-
Associate Medical Director
-
Highly Competitive
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
-
Account Director
-
Excellent benefits
-
New Business Director - PR
-
Competitive Salary and benefits
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Account Executive, London, Medical Communications
-
Excellent package
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Senior Medical Writer
-
Competitive Salary
Subscribe to our email news alerts
- Key considerations for disease- modifying Parkinson’s disease trials
- Artificial Intelligence In Healthcare Market to Witness Exponential Growth by 2027
- Breathing Exercise Devices Market Intelligence Report Offers Growth Prospects
- Micro-CT Scanners Market 10-Year Market Forecast and Trends Analysis Research Report
- Next Generation Infusion Pump Market Healthy Pace throughout the Forecast during 2017 – 2027
- Wireless Brain Sensors Market Intelligence Report Offers Growth Prospects
PMHub
Syneos Health™
Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
